» Articles » PMID: 34762835

Opportunities and Challenges in Closed-loop Systems in Type 1 Diabetes

Overview
Specialty Endocrinology
Date 2021 Nov 11
PMID 34762835
Citations 8
Authors
Affiliations
Soon will be listed here.
Citing Articles

Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead.

Grattoni A, Korbutt G, Tomei A, Garcia A, Pepper A, Stabler C Nat Rev Endocrinol. 2024; 21(1):14-30.

PMID: 39227741 DOI: 10.1038/s41574-024-01029-0.


Glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system 2-year prospective, observational, two-center study.

Seget S, Chobot A, Tarasiewicz M, Bielawska A, Rusak E, Ochab A Front Endocrinol (Lausanne). 2024; 15:1332418.

PMID: 38390211 PMC: 10882083. DOI: 10.3389/fendo.2024.1332418.


Integrating metabolic expenditure information from wearable fitness sensors into an AI-augmented automated insulin delivery system: a randomised clinical trial.

Jacobs P, Resalat N, Hilts W, Young G, Leitschuh J, Pinsonault J Lancet Digit Health. 2023; 5(9):e607-e617.

PMID: 37543512 PMC: 10557965. DOI: 10.1016/S2589-7500(23)00112-7.


Wearable Insulin Biosensors for Diabetes Management: Advances and Challenges.

Psoma S, Kanthou C Biosensors (Basel). 2023; 13(7).

PMID: 37504117 PMC: 10377143. DOI: 10.3390/bios13070719.


Quantifying insulin-mediated and noninsulin-mediated changes in glucose dynamics during resistance exercise in type 1 diabetes.

Young G, Jacobs P, Tyler N, Nguyen T, Castle J, Wilson L Am J Physiol Endocrinol Metab. 2023; 325(3):E192-E206.

PMID: 37436961 PMC: 10511169. DOI: 10.1152/ajpendo.00298.2022.


References
1.
Brown S, Kovatchev B, Raghinaru D, Lum J, Buckingham B, Kudva Y . Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. N Engl J Med. 2019; 381(18):1707-1717. PMC: 7076915. DOI: 10.1056/NEJMoa1907863. View

2.
Shah V, Garg S . Standardized Hybrid Closed-Loop System Reporting. Diabetes Technol Ther. 2020; 23(5):323-331. DOI: 10.1089/dia.2020.0622. View

3.
Tyler N, Mosquera-Lopez C, Wilson L, Dodier R, Branigan D, Gabo V . An artificial intelligence decision support system for the management of type 1 diabetes. Nat Metab. 2020; 2(7):612-619. PMC: 7384292. DOI: 10.1038/s42255-020-0212-y. View

4.
Johansson U, Amsberg S, Hannerz L, Wredling R, Adamson U, Arnqvist H . Impaired absorption of insulin aspart from lipohypertrophic injection sites. Diabetes Care. 2005; 28(8):2025-7. DOI: 10.2337/diacare.28.8.2025. View

5.
Agarwal S, Schechter C, Gonzalez J, Long J . Racial-Ethnic Disparities in Diabetes Technology use Among Young Adults with Type 1 Diabetes. Diabetes Technol Ther. 2020; 23(4):306-313. PMC: 7994432. DOI: 10.1089/dia.2020.0338. View